Key points are not available for this paper at this time.
Design
Editorial
Answers are grounded in this paper and cite their sources.
Discusses the challenges and necessity of funding a large-scale randomized trial comparing medical therapy to coronary revascularization to determine long-term benefits.
questions would be the performance of a randomized trial. We described such a trial in an editorial several years ago. 3 Currently, a pilot phase of a trial examining the influence of medical therapy versus revascularization in these patients is under way in the Veterans Affairs system. Although a similar trial has been proposed to the National Institutes of Health, this project has not received sufficient prioritization to be funded. Part of the funding concerns for this trial are due to the very large numbers and long-term follow-up that would be required to develop a satisfactory answer. Because the short-term risks of coronary revascularization for many patients can only be overcome by longterm benefit, any trial designed to study patients isolated to the perioperative period is not likely to show a benefit from revascularization.
No takes yet. Share an insight, caveat, or question.
Mark L. Metersky (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: